This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Sequence of chronic inflammation

Authoring team

The sequence of chronic inflammation centres around the activity of macrophages derived from blood monocytes. Most frequently, due to slower migration than neutrophils, they arrive at the site of inflammation after around 48 hours. In certain infections e.g. viral, they are the first cells to arrive.

The stimulus for transit is chemotactic factors released by the inflammatory agent or cells already at the scene e.g. lymphokines, PDGF, TFG beta, complement component C5a. The same range of substances ensure that during transit, macrophages are activated: primed for phagocytosis and intracellular killing.

Once at the site of inflammation, the macrophage is incapable of completing its role. This may be because:

  • it cannot phagocytose foreign particles because they are too large or have mechanisms to protect their destruction once in the phagocyte
  • the stimulus to chemotaxis and activation is:
    • overwhelming
    • persistent e.g. autoimmune reactions

As a consequence, more monocytes are recruited from the blood, more macrophages proliferate locally, and both groups are effectively stranded at the site. Increased macrophage activity and local destruction liberates a number of cytokines including interleukins and growth factors. These attract a range of supplementary cells including lymphocytes, fibroblasts, plasma cells, eosinophils and mast cells. The interaction between various cells is essential: lymphocytes and macrophages act in a complementary manner, each inducing the other's proliferation and differentiation via mediators such as interferon and interleukins.

Growth factors released in a haphazard manner cause random matrix-deposition, angiogenesis and epithelialization.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.